Ghent University Academic Bibliography

Show Sort by

Your filters: cql: keyword exact "angiogenesis" cql: author exact 802000815442 or (type exact bookEditor and editor exact 802000815442)

Add to list
- Journal Article
- A1
- open access
Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma

Yves-Paul Vandewynckel, Debby Laukens (UGent) , Lindsey Devisscher (UGent) , Eliene Bogaerts (UGent) , Annelies Paridaens (UGent) , Anja Van den Bussche (UGent) , Sarah Raevens (UGent) , Xavier Verhelst (UGent) , Christophe Van Steenkiste (UGent) , Bart Jonckx, et al.

(2016) BMC CANCER. 16.
Add to list
Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent

Yves-Paul Vandewynckel, Debby Laukens (UGent) , Anja Geerts (UGent) , Christian Vanhove (UGent) , Benedicte Descamps (UGent) , Isabelle Colle (UGent) , Lindsey Devisscher (UGent) , Eliene Bogaerts (UGent) , Annelies Paridaens (UGent) , Xavier Verhelst (UGent) , et al.

(2014) EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 26(8). p.861-870
Add to list
The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine induced mouse model

Femke Heindryckx (UGent) , Stephanie Coulon (UGent) , Ellen Terrie (UGent) , Christophe Casteleyn (UGent) , Jean-Marie Stassen, Anja Geerts (UGent) , Louis Libbrecht (UGent) , Joke Allemeersch, Peter Carmeliet, Isabelle Colle (UGent) , et al.

(2013) JOURNAL OF HEPATOLOGY. 58(2). p.319-328
Add to list
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models

Stephanie Coulon (UGent) , Vanessa Legry, Femke Heindryckx (UGent) , Christophe Van Steenkiste, Christophe Casteleyn (UGent) , Kim Olievier (UGent) , Louis Libbrecht (UGent) , Peter Carmeliet, Bart Jonckx, Jean-Marie Stassen, et al.

(2013) HEPATOLOGY. 57(5). p.1793-1805
Add to list
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model

Femke Heindryckx (UGent) , Eliene Bogaerts (UGent) , Stephanie Coulon (UGent) , Hilde Devlies (UGent) , Anja Geerts (UGent) , Louis Libbrecht (UGent) , Jean Marie Stassen, Peter Carmeliet, Isabelle Colle (UGent) and Hans Van Vlierberghe (UGent)

(2012) EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 24(9). p.1020-1032
Add to list
Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice

Femke Heindryckx (UGent) , Anna Kuchnio, Christophe Casteleyn (UGent) , Stephanie Coulon (UGent) , Kim Olievier (UGent) , Isabelle Colle (UGent) , Anja Geerts (UGent) , Louis Libbrecht (UGent) , Peter Carmeliet and Hans Van Vlierberghe (UGent)

(2012) JOURNAL OF HEPATOLOGY. 57(1). p.61-68
Add to list
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

Christophe Van Steenkiste (UGent) , Jordi Ribera, Anja Geerts (UGent) , Montse Pauta, Sonia Tugues, Christophe Casteleyn (UGent) , Louis Libbrecht (UGent) , Kim Olievier (UGent) , Ben Schroyen, Hendrik Reynaert, et al.

(2011) HEPATOLOGY. 53(5). p.1629-1640
Add to list
- Journal Article
- A1
- open access
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

Femke Heindryckx (UGent) , Koen Mertens (UGent) , Nicolas Charette, Bert Vandeghinste (UGent) , Christophe Casteleyn (UGent) , Christophe Van Steenkiste (UGent) , Dominique Slaets (UGent) , Louis Libbrecht (UGent) , Steven Staelens (UGent) , Peter Starkel, et al.

(2010) MOLECULAR CANCER. 9.

Academic Bibliography

Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma

Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent

The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine induced mouse model

Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models

Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model

Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

Contents

Support

Contact